Different studies reported MDS transformation to AML with a frequency between 6% [72,82] and 12.8% [91]; one possible explanation may be the simultaneous presence of deletion 5q and JAK2 V617F gene mutation and other gene mutations (for example, TP53). This evidence concerns the gene JAK2 and acute myeloid leukemia.